ArticleNature communications2021

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.

Kevin Alicea-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.